Tirzepatide is a dual GIP and GLP-1 receptor agonist that has been extensively studied for its effects on weight management, appetite, blood sugar regulation, and overall metabolic health.

BENEFITS & AREAS OF INTEREST

• WEIGHT MANAGEMENT – Clinical studies have demonstrated significant reductions in body weight in adults with overweight or obesity.

• APPETITE REGULATION – Helps reduce appetite and food intake while increasing feelings of fullness and satiety.

• BLOOD SUGAR CONTROL – Improves blood glucose regulation and A1C in adults with type 2 diabetes.

• METABOLIC HEALTH – Research has demonstrated improvements in several cardiometabolic measures, including waist circumference and certain lipid and blood-pressure measures.

• CARDIOVASCULAR HEALTH – Tirzepatide has been studied for its effects on cardiovascular risk and outcomes in people with obesity and/or type 2 diabetes.

IMPORTANT: FDA-approved tirzepatide products are prescription medications approved for specific indications. Product formulation, dosing, safety, contraindications, and appropriate use should be determined by a licensed healthcare professional. A product labeled “for research use only” should not be represented or used as an FDA-approved medication.